Ligand Pharmaceuticals
LGND
286.85
-0.09
-0.03%
Ligand Pharmaceuticals
US · LGND
#1920 by market cap
Listed 1970
286.85
-0.09
-0.03%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Ligand Pharmaceuticals
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
- Founded
- 1987
- CEO
- Mr. Todd C. Davis
- Employees
- 47
- Headquarters
- Jupiter, Florida, United States of America
- Fiscal year end
- 12-31
- Website
- ligand.com
Company profile
- Exchange
- US
- Symbol
- LGND
- Market-cap rank
- #1920
- Listing date
- 1970-01-01
- Market cap
- 5.74B
- Float cap
- 5.61B
- Shares out
- 20.00M
- Float shares
- 19.56M
Sectors & themes
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Ligand Pharmaceuticals discussion 0 comments